SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor drug development in depression? Does mismatch negativity have utility for NMDA receptor drug development in depression?

Por um escritor misterioso

Descrição

Rapid antidepressant effects associated with ketamine have shifted the landscape for the
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Molecular mechanisms underlying the antidepressant actions of
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Consequences of isolation in elderly with and without
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
mGlu1 potentiation enhances prelimbic somatostatin interneuron
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Cannabinoids and Vanilloids in Schizophrenia
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Does mismatch negativity have utility for NMDA receptor drug
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
SciELO - Brazil - Does mismatch negativity have utility for NMDA
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Using the pharmacology of latent inhibition to model domains
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
PDF) Changing prevalence and treatment of depression among older
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Depression and the NMDA receptor/NO/cGMP pathway - ScienceDirect
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
The deubiquitinase USP6 affects memory and synaptic plasticity
SciELO - Brazil - Does mismatch negativity have utility for NMDA receptor  drug development in depression? Does mismatch negativity have utility for  NMDA receptor drug development in depression?
Signaling pathways responsible for the rapid antidepressant-like
de por adulto (o preço varia de acordo com o tamanho do grupo)